A genomic variant of ALPK2 is associated with increased liver fibrosis risk in HIV/HCV coinfected women
View ORCID ProfileAlec T. McIntosh, Renhuizi Wei, View ORCID ProfileJaeil Ahn, Brad E. Aouizerat, View ORCID ProfileSeble G. Kassaye, Michael H. Augenbraun, Jennifer C. Price, Audrey L. French, View ORCID ProfileStephen J. Gange, View ORCID ProfileKathryn M. Anastos, View ORCID ProfileRadoslav Goldman
doi: https://doi.org/10.1101/2020.09.28.20201202
Alec T. McIntosh
1Department of Oncology, Georgetown University, Washington, DC
Renhuizi Wei
1Department of Oncology, Georgetown University, Washington, DC
Jaeil Ahn
2Department of Biostatistics, Bioinformatics & Biomathematics, Georgetown University Medical Center, Washington, DC
Brad E. Aouizerat
3Bluestone Center for Clinical Research, College of Dentistry, New York University, New York, NY
Seble G. Kassaye
4Department of Infectious Diseases, Georgetown University Medical Center, Washington, DC
Michael H. Augenbraun
5Department of Medicine, Division of Infectious Diseases, State University of New York, Downstate Medical Center, Brooklyn, NY
Jennifer C. Price
6Department of Medicine, Division of Liver Diseases, University of California San Francisco, San Francisco, CA
Audrey L. French
7Department of Internal Medicine, Division of Infectious Disease, Stroger Hospital of Cook County, Chicago, IL
Stephen J. Gange
8Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD
Kathryn M. Anastos
9Departments of Medicine and Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY
Radoslav Goldman
1Department of Oncology, Georgetown University, Washington, DC
10Department of Biochemistry and Molecular & Cell Biology, Georgetown University Medical Center, Washington, DC
11Clinical Translational Glycoscience Research Center, Georgetown University Medical Center, Washington, DC

Article usage
Posted September 29, 2020.
A genomic variant of ALPK2 is associated with increased liver fibrosis risk in HIV/HCV coinfected women
Alec T. McIntosh, Renhuizi Wei, Jaeil Ahn, Brad E. Aouizerat, Seble G. Kassaye, Michael H. Augenbraun, Jennifer C. Price, Audrey L. French, Stephen J. Gange, Kathryn M. Anastos, Radoslav Goldman
medRxiv 2020.09.28.20201202; doi: https://doi.org/10.1101/2020.09.28.20201202
A genomic variant of ALPK2 is associated with increased liver fibrosis risk in HIV/HCV coinfected women
Alec T. McIntosh, Renhuizi Wei, Jaeil Ahn, Brad E. Aouizerat, Seble G. Kassaye, Michael H. Augenbraun, Jennifer C. Price, Audrey L. French, Stephen J. Gange, Kathryn M. Anastos, Radoslav Goldman
medRxiv 2020.09.28.20201202; doi: https://doi.org/10.1101/2020.09.28.20201202
Subject Area
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (728)
- Anesthesia (215)
- Cardiovascular Medicine (3126)
- Dermatology (265)
- Emergency Medicine (464)
- Epidemiology (13076)
- Forensic Medicine (14)
- Gastroenterology (868)
- Genetic and Genomic Medicine (4895)
- Geriatric Medicine (451)
- Health Economics (755)
- Health Informatics (3089)
- Health Policy (1109)
- Hematology (411)
- HIV/AIDS (973)
- Medical Education (457)
- Medical Ethics (121)
- Nephrology (502)
- Neurology (4664)
- Nursing (248)
- Nutrition (691)
- Oncology (2405)
- Ophthalmology (683)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (311)
- Palliative Medicine (88)
- Pathology (519)
- Pediatrics (1249)
- Primary Care Research (526)
- Public and Global Health (7231)
- Radiology and Imaging (1613)
- Respiratory Medicine (945)
- Rheumatology (462)
- Sports Medicine (403)
- Surgery (518)
- Toxicology (65)
- Transplantation (222)
- Urology (193)